Browse diseases

…ter optimisation and class weighting to predict 5-year incident type 2 diabetes using demographic, clinical and polygenic predictors. Stage 2 i…

…etween the groups in the rates of adverse events.Conclusions In type 2 diabetes individuals with mild-to-moderate symptomatic DSPN, treatment w…

…ction may be indicated to achieve greater therapeutic benefit B.Obesity is a heterogeneous disease with varying effects on health, nece…

…ological pathways linking metals, clinical factors, and diet to diabetes risk Multiple, non-mutually exclusive pathways may explain how …

…itors or ARBs) are the foundational nephroprotective therapy in lupus nephritis with persistent proteinuria, and should be initiated in all pat…

…onists; SGLT-2i, sodium-glucose cotransporter-2 inhibitors; TC, thyroid cancer.The results for the secondary analyses based on the three addit…

…participants (Classes C, D, E) who displayed highly accelerated T2D progression, as defined by a greater degree of medication trans…

…istration number 000054359). Participants were individuals with type 2 diabetes who were aged 18 years or older and who had either been using m…

…arget, phase 3, non-inferiority trial involving 795 adults with type 2 diabetes who had not previously received insulin therapy. The study was …

…diovascular, kidney, and weight related outcomes in people with type 2 diabetes. Dynamically updated practice guidelines adhering to standards …

…Abstract Type 2 diabetes poses a substantial public health challenge in South Asia, mark…

…participating clinics.Participants A total of 996 patients with type 2 diabetes from the non-intervention group were included in the analysis. …